Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
Corindus Vascular Robotics (CVRS) PT Raised to $2 at Ladenburg Thalmann
March 13, 2019 9:18 AM EDTLadenburg Thalmann analyst Jeffrey Cohen raised the price target on Corindus Vascular Robotics (NYSE: CVRS) to $2.00 (from $1.70) while maintaining a Buy rating following the company's 4Q. Revenue, net loss, and loss per share for the quarter was $4.7 million, $7.4 million, and $0.04. Consensus estimate for the quarter were... More
